Effects of Upper Limb Motor and Robotic Training Over Neuroplasticity and Function Capacity (NARLE1)
Primary Purpose
Stroke
Status
Unknown status
Phase
Phase 2
Locations
Brazil
Study Type
Interventional
Intervention
Robotic occupational therapy
Induced Constraint Therapy - ICT
Sponsored by

About this trial
This is an interventional treatment trial for Stroke focused on measuring Induced Constraint Therapy, Robotic Occupational Therapy, Neuroplasticity
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of stroke;
- Patients from 6 months after stroke up to 36 months after stroke;
- Clinically stable;
- Upper limb Brunnstrom scale III or IV;
- Brunnstrom scale above V if clinician supports patients will benefit from treatment;
- Minimum wrist extension of 20°, and minimum of 10° of metacarpophalangeal active extension.
- Signed Informed Consent Form;
Exclusion Criteria:
- Mini-Mental score lower than 20 points;
- Previous multiple strokes;
- Bone diseases and articulation injuries ;
- Presence of psychological disturbances capable of diminishing adherence;
- Articulation pain within the range of motion proposed by the therapies;
- Participation in another study protocol for upper limbs therapies.
- Previous treatment with robotic assisted therapies.
Sites / Locations
- Centro de Pesquisa Clínica do Instituto de Medicina Física e Reabilitação do HCFMUSP
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Induced Constraint Therapy - ICT
Robotic occupational therapy
Arm Description
Physical rehabilitation with Induced Constraint Therapy as part of the occupational therapy. Standard Occupational Therapy two times a week for ten weeks, followed by two whole weeks of Induced Constraint Therapy.
Physical rehabilitation with Robotic occupational therapy. Robotic Occupational Therapy three times a week for twelve weeks.
Outcomes
Primary Outcome Measures
Change on Motor Function assessed by Wolf Motor Function scale
Change from baseline in Wolf Motor Function scale.
Change on Motor Function assessed by Fugl Meyer scale
Change from baseline in Fugl Meyer scale.
Secondary Outcome Measures
Change on Motor Function assessed by Wolf Motor Function scale
Multiple changes from baseline in Wolf Motor Function scale.
Change on Motor Function assessed by Fugl Meyer scale
Multiple changes from baseline in Fugl Meyer scale.
Change on Motor Function assessed by Robotic scale
Multiple changes from baseline in robotic scale.
Change on Function ability and quality of movement assessed by Arm Motor Ability Test (AMAT)
Multiple changes from baseline in AMAT scale.
Change on Functional Independence Measure (FIM) as assessed by FIM scale
Multiple changes from baseline in FIM scale.
Change on Quality of life assessed by Stroke Impact Scale (SIS)
Multiple changes from baseline in SIS.
Change on Kinematic variables assessed by InMotion robots
Multiple motion changes from baseline in the Kinematic variables assessed by InMotion robots.
Full Information
NCT ID
NCT02700061
First Posted
November 24, 2015
Last Updated
March 1, 2016
Sponsor
University of Sao Paulo General Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02700061
Brief Title
Effects of Upper Limb Motor and Robotic Training Over Neuroplasticity and Function Capacity
Acronym
NARLE1
Official Title
Effects of Upper Limb Motor Training and Upper Limb Robotic Training Over Neuroplasticity and Function Capacity: A Single-blind Randomized Clinical Trial With Patients With Stroke Sequelae
Study Type
Interventional
2. Study Status
Record Verification Date
August 2015
Overall Recruitment Status
Unknown status
Study Start Date
February 2012 (undefined)
Primary Completion Date
April 2016 (Anticipated)
Study Completion Date
February 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Sao Paulo General Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to evaluate and compare the effects of upper limb training with Induced Constraint Therapy (ICT) or robotic therapy. No placebo therapy is used. Motor function, neurological evaluations and quality of life are assessed for the comparison of the therapies.
Detailed Description
The trial is being carried out in the Institute of Physical Medicine and Rehabilitation of the University of São Paulo since February 2012. The investigators are including patients with clinical diagnosis of Ischemic or hemorrhagic stroke.
The patients are being randomized in blocks of four, six and eight, in two arms: ICT: patients are undergoing 60 minutes physiotherapy and occupational therapy twice a week for ten consecutive weeks. Other therapeutic services as phonoaudiology, psychology, nutrition, physical conditioning are prescribed upon the patients' medical demands. After the 10 weeks, the patients are undergoing two whole weeks of daily ICT as to reach 90% of the time under constraint, including weekends. During this last period, no other therapeutic service is offered, but the occupational therapy under ICT. Patients are not allowed to undergo robotic therapy.
Robotic therapy: patients are undergoing robotic occupational therapy for 60 minutes, three times a week for twelve consecutive weeks. All other therapeutic services are prescribed upon the patients' medical demands. Patients are not allowed to undergo ICT.
The investigator and the raters are blind to treatment.
The evaluations are done prior to the beginning of the treatment and at the end of it. The follow up assessments are done at 3 and 12 months after the end of the treatment.
The sample size was estimated to be 62 patients in each arm, a total size of 124 patients
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
Induced Constraint Therapy, Robotic Occupational Therapy, Neuroplasticity
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
51 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Induced Constraint Therapy - ICT
Arm Type
Experimental
Arm Description
Physical rehabilitation with Induced Constraint Therapy as part of the occupational therapy. Standard Occupational Therapy two times a week for ten weeks, followed by two whole weeks of Induced Constraint Therapy.
Arm Title
Robotic occupational therapy
Arm Type
Experimental
Arm Description
Physical rehabilitation with Robotic occupational therapy. Robotic Occupational Therapy three times a week for twelve weeks.
Intervention Type
Procedure
Intervention Name(s)
Robotic occupational therapy
Other Intervention Name(s)
Robotic therapy
Intervention Description
Robotic Occupational Therapy three times a week for twelve weeks.
Intervention Type
Procedure
Intervention Name(s)
Induced Constraint Therapy - ICT
Other Intervention Name(s)
ICT
Intervention Description
Standard Occupational Therapy two times a week for ten weeks, followed by two whole weeks of Induced Constraint Therapy.
Primary Outcome Measure Information:
Title
Change on Motor Function assessed by Wolf Motor Function scale
Description
Change from baseline in Wolf Motor Function scale.
Time Frame
Baseline and 12 weeks
Title
Change on Motor Function assessed by Fugl Meyer scale
Description
Change from baseline in Fugl Meyer scale.
Time Frame
Baseline and 12 weeks
Secondary Outcome Measure Information:
Title
Change on Motor Function assessed by Wolf Motor Function scale
Description
Multiple changes from baseline in Wolf Motor Function scale.
Time Frame
Baseline, 3 months and 12 months
Title
Change on Motor Function assessed by Fugl Meyer scale
Description
Multiple changes from baseline in Fugl Meyer scale.
Time Frame
Baseline, 3 months and 12 months
Title
Change on Motor Function assessed by Robotic scale
Description
Multiple changes from baseline in robotic scale.
Time Frame
Baseline, 3 months and 12 months
Title
Change on Function ability and quality of movement assessed by Arm Motor Ability Test (AMAT)
Description
Multiple changes from baseline in AMAT scale.
Time Frame
Baseline, 12 weeks, 3 months and 12 months
Title
Change on Functional Independence Measure (FIM) as assessed by FIM scale
Description
Multiple changes from baseline in FIM scale.
Time Frame
Baseline, 12 weeks, 3 months and 12 months
Title
Change on Quality of life assessed by Stroke Impact Scale (SIS)
Description
Multiple changes from baseline in SIS.
Time Frame
Baseline, 12 weeks, 3 months and 12 months
Title
Change on Kinematic variables assessed by InMotion robots
Description
Multiple motion changes from baseline in the Kinematic variables assessed by InMotion robots.
Time Frame
Baseline, 12 weeks, 3 months and 12 months
Other Pre-specified Outcome Measures:
Title
Psychological Evaluation assessed by Perceived Stress Scale (PSS-10)
Description
Multiple changes from baseline in PSS-10.
Time Frame
Baseline, 12 weeks, 3 months and 12 months
Title
Neuroplasticity as assessed by Brain Derived Neurotrophic Factor (BDNF)
Description
Multiple changes from baseline in BDNF.
Time Frame
Baseline, 12 weeks, 3 months and 12 months
Title
Corticospinal excitability as assessed by transcranial magnetic stimulation (TMS)
Description
Multiple changes from baseline in TMS.
Time Frame
Baseline, 12 weeks, 3 months and 12 months
Title
Neurologic evaluation as assessed by electroencephalography
Description
Multiple changes from baseline in electroencephalography.
Time Frame
Baseline, 12 weeks, 3 months and 12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical diagnosis of stroke;
Patients from 6 months after stroke up to 36 months after stroke;
Clinically stable;
Upper limb Brunnstrom scale III or IV;
Brunnstrom scale above V if clinician supports patients will benefit from treatment;
Minimum wrist extension of 20°, and minimum of 10° of metacarpophalangeal active extension.
Signed Informed Consent Form;
Exclusion Criteria:
Mini-Mental score lower than 20 points;
Previous multiple strokes;
Bone diseases and articulation injuries ;
Presence of psychological disturbances capable of diminishing adherence;
Articulation pain within the range of motion proposed by the therapies;
Participation in another study protocol for upper limbs therapies.
Previous treatment with robotic assisted therapies.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Linamara Rizzo Battistella, Md PhD
Organizational Affiliation
University of Sao Paulo
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centro de Pesquisa Clínica do Instituto de Medicina Física e Reabilitação do HCFMUSP
City
Sao Paulo
ZIP/Postal Code
04116-040
Country
Brazil
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
34366819
Citation
Terranova TT, Simis M, Santos ACA, Alfieri FM, Imamura M, Fregni F, Battistella LR. Robot-Assisted Therapy and Constraint-Induced Movement Therapy for Motor Recovery in Stroke: Results From a Randomized Clinical Trial. Front Neurorobot. 2021 Jul 21;15:684019. doi: 10.3389/fnbot.2021.684019. eCollection 2021.
Results Reference
derived
Learn more about this trial
Effects of Upper Limb Motor and Robotic Training Over Neuroplasticity and Function Capacity
We'll reach out to this number within 24 hrs